EBITDA multiples for lower middle market healthcare staffing agencies range from 3.5x to 6x — but your final valuation depends on contract quality, clinician database depth, compliance infrastructure, and how replaceable you are as the owner.
Find Medical Staffing Agency Businesses For SaleMedical staffing agencies in the lower middle market are primarily valued on a multiple of Seller's Discretionary Earnings (SDE) for smaller owner-operated firms, or EBITDA for agencies generating $500K or more in annual earnings. Buyers apply multiples ranging from 3.5x to 6x depending on the quality of client contracts, revenue diversification, recruiter retention risk, and compliance standing. Agencies with signed master service agreements, Joint Commission accreditation, and a proprietary database of 500 or more credentialed clinicians consistently command premiums at the higher end of the range.
3.5×
Low EBITDA Multiple
4.75×
Mid EBITDA Multiple
6×
High EBITDA Multiple
A 3.5x multiple typically reflects agencies with high client concentration (one or two hospital systems representing 50%+ of revenue), owner-dependent recruiter relationships, thin gross margins below 18%, or informal credentialing processes. A mid-range multiple of 4.5x–5x applies to agencies with diversified client rosters, documented compliance workflows, and some recurring MSP or preferred vendor revenue. Agencies earning 6x or above demonstrate multi-year client contracts across several health systems, a self-sustaining recruiting team, Joint Commission accreditation, and year-over-year revenue growth in a specialty niche such as travel nursing, ICU, or behavioral health staffing.
$3.2M
Revenue
$640K
EBITDA
4.75x
Multiple
$3.04M
Price
$2.28M SBA 7(a) loan (75%), $304K buyer equity injection (10%), $304K seller note at 6% interest over 24 months (10%), $152K earnout tied to 90% client revenue retention and $600K EBITDA in year one post-close (5%). The seller remains engaged as a consultant for six months at a fixed fee to facilitate recruiter introductions and MSP contract transitions.
EBITDA Multiple
The most common valuation method used by institutional buyers and PE-backed roll-up platforms. Adjusted EBITDA is calculated after normalizing owner compensation, removing non-recurring expenses, and stripping out pass-through payroll costs that inflate gross revenue figures. A market multiple of 3.5x–6x is then applied based on agency-specific risk factors.
Best for: Agencies generating $500K or more in annual EBITDA with at least $2M in net revenue, especially those targeting PE or strategic acquirers
Seller's Discretionary Earnings (SDE) Multiple
Used for smaller owner-operated agencies where the owner functions as a recruiter, account manager, or compliance officer. SDE adds back the owner's full compensation, personal benefits, and one-time expenses to net income. Multiples of 2.5x–4x SDE are typical at this level, reflecting the higher key-person risk inherent in smaller operations.
Best for: Owner-operated agencies under $2M in revenue where a single individual drives the majority of recruiter relationships and day-to-day operations
Revenue Multiple
Occasionally used as a sanity check or screening tool by strategic acquirers, particularly when EBITDA is compressed by heavy payroll float or reinvestment. Healthcare staffing agencies at this revenue level typically trade at 0.4x–0.8x gross revenue, with higher multiples reserved for agencies with strong recurring contract revenue and low client churn.
Best for: Initial screening by strategic buyers or roll-up operators comparing multiple acquisition targets quickly before committing to full diligence
Diversified Client Base Across Multiple Health Systems
Agencies where no single hospital system, long-term care network, or outpatient group represents more than 25% of total billings are significantly more attractive to buyers. Client diversification reduces revenue concentration risk, provides negotiating leverage during contract renewals, and signals that the agency's value is embedded in its systems and reputation rather than a single relationship.
Signed Multi-Year Master Service Agreements or Preferred Vendor Status
Contractually protected revenue through MSP or preferred vendor arrangements with health systems is the single strongest valuation lever in this industry. These agreements signal predictable demand, reduced churn risk, and a competitive moat that cannot be easily replicated by a new entrant or internal float pool. Buyers will pay premium multiples for agencies with 12–36 months of remaining contract term on key accounts.
Proprietary ATS and Credentialing Database with 500+ Active Clinicians
A well-maintained applicant tracking system containing credentialed, compliant, and currently available nurses, allied health professionals, or locum tenens physicians represents years of recruiter investment that buyers cannot easily recreate. Agencies with documented licensure verification, background check records, and Joint Commission-compliant onboarding files for 500 or more active clinicians command meaningful valuation premiums.
Self-Sustaining Recruiting and Account Management Team
Buyers pay significantly more for agencies where the owner is not the primary recruiter or the sole relationship manager for top clients. An agency with two or more experienced recruiters, an account manager covering key health system contacts, and documented workflows for onboarding and credentialing can survive an ownership transition without client or clinician attrition — which is exactly what buyers are paying for.
Joint Commission Accreditation or State-Specific Certification
Accreditation from The Joint Commission or equivalent state certification demonstrates a commitment to compliance infrastructure that many hospital clients now require as a condition of vendor approval. Agencies holding active accreditation have a built-in competitive advantage in winning new health system contracts and signal to buyers that credentialing and quality standards are systematized rather than ad hoc.
Specialty Niche Focus with Premium Bill Rates
Agencies specializing in high-demand clinical disciplines — such as intensive care, operating room, behavioral health, or labor and delivery nursing — typically achieve bill rates 15–30% above general per diem placements. Niche focus creates pricing power, reduces direct competition from generalist staffing firms, and results in stronger gross margins that support higher EBITDA multiples at exit.
Heavy Client Concentration in One or Two Accounts
If a single hospital system or healthcare group represents 50% or more of total billings, most institutional buyers will discount the valuation by 1–2 turns of EBITDA or require a meaningful earnout tied to retention of that client post-close. This concentration risk reflects the reality that hospital procurement teams regularly consolidate vendor lists, and losing one anchor client could cut agency revenue in half overnight.
Owner Acting as Primary Recruiter or Sole Client Relationship Holder
When the selling owner is personally known to hospital HR directors, manages the agency's top clinician relationships, or functions as the de facto lead recruiter, buyers face a transition risk that is difficult to price. This key-person dependency is one of the most common reasons deals are structured with earnouts or seller equity rollovers rather than clean cash-at-close transactions.
Pending Wage-and-Hour Litigation or Worker Misclassification Exposure
Healthcare staffing agencies that have misclassified clinicians as independent contractors rather than W-2 employees face significant back-tax liability, penalties from state labor boards, and potential class action exposure. Similarly, agencies with unresolved wage-and-hour claims or history of overtime violations will face intense scrutiny during diligence and may see deals collapse entirely, as buyers are unwilling to absorb these contingent liabilities.
Gross Margins Below 18%
Thin gross margins are a red flag that the agency has over-indexed on low-markup shift-fill contracts, is not charging premium rates for specialized placements, or is absorbing excessive payroll costs without adequate billing rate discipline. Most buyers target agencies with gross margins of 20–30%, and anything below 18% signals either a pricing problem or an over-reliance on commodity per diem volume that can easily be undercut by larger competitors.
Informal or Undocumented Credentialing Processes
Agencies that cannot produce complete credentialing files — including current licensure verification, background checks, health screenings, and competency assessments for each active clinician — expose buyers to post-acquisition liability with hospital clients and regulatory bodies. During diligence, gaps in credentialing documentation are frequently used to justify price reductions or representations-and-warranties insurance requirements that increase deal complexity and cost.
Revenue Volatility from Crisis-Rate Travel Nurse Dependency
Agencies that grew rapidly during the 2021–2023 COVID-era travel nurse demand surge and have not successfully transitioned to normalized contract rates are showing significant revenue declines that concern buyers. Year-over-year revenue volatility greater than 20% makes it difficult to establish a reliable EBITDA baseline for valuation purposes and signals that the agency lacks the diversified revenue mix needed to sustain performance through demand cycles.
Find Medical Staffing Agency Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most lower middle market medical staffing agencies sell for 3.5x to 6x adjusted EBITDA. The specific multiple you receive depends on several factors: client diversification, contract quality, gross margin, recruiter team stability, and your compliance infrastructure. Agencies with multi-year MSP agreements, Joint Commission accreditation, and a self-sustaining recruiting team regularly achieve multiples of 5x or higher. Owner-dependent agencies with thin margins and informal credentialing processes typically land in the 3.5x–4x range.
Buyers start with your agency's net income and add back interest, taxes, depreciation, and amortization. They then make adjustments for owner compensation above or below market rate, personal expenses run through the business, one-time costs, and any non-recurring revenue. A critical adjustment specific to staffing agencies is separating true operating expenses from pass-through payroll costs — buyers focus on gross margin dollars rather than top-line revenue because staffing revenue is inflated by clinician wages that flow straight through the business.
Yes. Medical staffing agencies are generally SBA 7(a) eligible because they are service businesses with tangible cash flow, established client relationships, and identifiable assets including the clinician database and client contracts. A typical SBA-financed acquisition requires the buyer to inject 10–20% equity, with the remainder funded through the SBA loan. Sellers are often asked to carry a note of 5–10% to demonstrate confidence in the transition. The SBA loan is repaid over 10 years, making the debt service manageable relative to the agency's ongoing EBITDA.
PE-backed healthcare staffing platforms and roll-up operators are looking for tuck-in acquisitions that add geographic coverage, clinical specialty capabilities, or a credentialed clinician database they can leverage across their existing platform. Attractive targets have minimum $500K EBITDA, active contracts with multiple health systems, a recruiting team that can operate independently of the seller, and a clean compliance history. Agencies with Joint Commission accreditation or established MSP relationships are especially valuable because they provide immediate access to contracted revenue streams that would take years to build from scratch.
The most effective way to reduce key-person risk is to systematically transfer client relationships and recruiter workflows away from yourself before going to market. This means introducing a senior account manager or recruiter to all key hospital contacts, documenting your recruiting and credentialing processes in a written operations manual, and creating stay bonuses tied to post-close milestones for your top two or three staff members. Starting this process 12–18 months before your target sale date gives you time to demonstrate that the agency runs without you, which is the single most important factor in achieving a premium multiple.
Client concentration is one of the most scrutinized risk factors in any healthcare staffing acquisition. If one hospital system or healthcare group represents more than 30–40% of your billings, buyers will typically discount your valuation, require a retention earnout tied to that client's continued revenue post-close, or both. The ideal profile is no single client exceeding 20–25% of total revenue. If you have concentration risk, the best mitigation strategy is to spend 12–18 months actively diversifying your client roster before bringing the agency to market.
Before going to market, conduct an internal audit of three key compliance areas. First, verify that all active clinicians have complete and current credentialing files including licensure, background checks, health screenings, and competency documentation. Second, confirm that all clinicians are properly classified as W-2 employees rather than independent contractors, which is a common IRS and state labor board challenge in this industry. Third, review your state staffing licenses, tax registrations, and any Joint Commission or accreditation certificates to confirm they are current and transferable. Buyers will hire healthcare compliance counsel to review these materials during diligence, and gaps discovered late in the process can delay closing or reduce your final price.
The most common structure in the lower middle market combines an SBA 7(a) loan covering 70–80% of the purchase price, a buyer equity injection of 10–20%, and a seller note of 5–10% subordinated to the SBA loan and repaid over 12–24 months. For agencies with client concentration risk or revenue volatility, buyers often add an earnout of 5–15% of the purchase price tied to revenue retention and EBITDA performance over the first one to two years post-close. PE-backed platform acquirers may offer sellers a 15–25% equity rollover in the platform entity as a way to participate in the upside of future roll-up exits rather than taking all cash at close.
More Medical Staffing Agency Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers